SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹1,465 Cr | ₹1,273 Cr | ₹936 Cr | ₹615 Cr | ₹391 Cr |
What is the latest Profit & Loss Account Balance ratio of SUVEN PHARMACEUTICALS ?
Year | Profit & Loss Account Balance |
---|---|
Mar2023 | ₹1,465 Cr |
Mar2022 | ₹1,273 Cr |
Mar2021 | ₹936 Cr |
Mar2020 | ₹615 Cr |
Mar2019 | ₹391 Cr |
How is Profit & Loss Account Balance of SUVEN PHARMACEUTICALS Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2023 | ₹1,465 Cr | 15.12 | |
Mar2022 | ₹1,273 Cr | 35.90 | |
Mar2021 | ₹936 Cr | 52.17 | |
Mar2020 | ₹615 Cr | 57.41 | |
Mar2019 | ₹391 Cr | - |
Compare Profit & Loss Account Balance of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,439.5 Cr | -0.6% | -0.7% | 35.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -0.6% |
-0.7% |
35.1% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses